Patent details

EP3866765 Title: INJECTABLE LONG-ACTING NALTREXONE MICROPARTICLE COMPOSITIONS

Basic Information

Publication number:
EP3866765
PCT Application Number:
KR2019013535
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP198743387
PCT Publication Number:
WO2020080806
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INJECTABLE LONG-ACTING NALTREXONE MICROPARTICLE COMPOSITIONS
French Title of Invention:
COMPOSITIONS INJECTABLES DE MICROPARTICULES DE NALTREXONE À ACTION PROLONGÉE
German Title of Invention:
INJIZIERBARE LANGWIRKENDE NALTREXONMIKROPARTIKELZUSAMMENSETZUNGEN
SPC Number:

Dates

Filing date:
15/10/2019
Grant date:
07/02/2024
EP Publication Date:
25/08/2021
PCT Publication Date:
23/04/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/02/2024
EP B1 Publication Date:
07/02/2024
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/10/2024
Expiration date:
15/10/2039
Renunciation date:
Revocation date:
27/08/2025
Annulment date:

Owner

From:
31/01/2024
 
 

Name:
Chong Kun Dang Pharmaceutical Corp.
Address:
8, Chungjeong-ro Seodaemun-gu, Seoul 03742, Korea (Republic) (KR)

Name:
Purdue Research Foundation
Address:
1801 Newman Road, West Lafayette, Indiana 47906, United States (US)

Inventor

1

Name:
OTTE, Andrew David
Address:
United States (US)

2

Name:
PARK, Kinam
Address:
United States (US)

3

Name:
YOON, Gwangheum
Address:
United States (US)

4

Name:
SOH, Bong Kwan
Address:
United States (US)

Priority

Priority Number:
201862745805 P
Priority Date:
15/10/2018
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/16; A61K 31/485; A61P 25/04;

Publication

European Patent Bulletin

1

Issue number:
202406
Publication date:
07/02/2024
Description:
Grant (B1)

2

Issue number:
202601
Publication date:
31/12/2025
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages